Institutional investors boost holdings in Abivax and Avantis International Equity ETFs

AdvisorShares Investments LLC disclosed a new stake of 11,200 shares in Abivax SA Sponsored ADR, valued at roughly $1.5 million. Several other institutional investors also raised positions, including Bank of America (5,536 shares), Cubist Systematic Strategies (10,152 shares), Millennium Management (987,414 shares), Woodline Partners (201,924 shares) and XTX Topco Ltd (new position). Abivax, a clinical‑stage biopharma based in Paris, has a market capitalisation of about $10.6 billion and reported quarterly revenue of $1.56 million.

ARK & TLK Investments LLC increased its holding in the Avantis International Equity ETF by 41 % to 50,954 shares, worth $4.2 million. Other investors expanding the fund’s stake include Royal Bank of Canada (80,754 shares), Integrated Wealth Concepts (6,692 shares), Cetera Investment Advisers (4,756 shares), Baird Financial Group (7,011 shares) and Quantinno Capital Management (6,013 shares). The ETF tracks the MSCI World ex‑USA IMI Index, has a market capitalisation of $16.1 billion and a P/E ratio of 14.71.